{"id":9804,"date":"2018-01-25T10:58:53","date_gmt":"2018-01-25T09:58:53","guid":{"rendered":"https:\/\/frezzapartners.com\/?p=9804"},"modified":"2018-01-26T14:39:04","modified_gmt":"2018-01-26T13:39:04","slug":"cambi-ai-veritici-novartis","status":"publish","type":"post","link":"https:\/\/frezzapartners.com\/en\/cambi-ai-veritici-novartis\/","title":{"rendered":"Cambi ai vertici Novartis"},"content":{"rendered":"<p>Photo by Samuel Ferrara<\/p>\n<p>&nbsp;<\/p>\n<p>Dopo l&#8217;entrata di Pasquale Frega nel ruolo di Country President Italy e AD Novartis Farma, l&#8217;abbandono &#8211; ufficiale fra qualche giorno &#8211; di<strong> Joseph Jimenez. <\/strong><\/p>\n<p>Gi\u00e0 <em>Chief Executive Officer<\/em> (CEO) di Novartis, Jimenez aveva informato il Consiglio di Amministrazione della sua volont\u00e0 di dimettersi dall\u2019incarico nel settembre scorso, nel dopo otto anni. Al suo posto, il Consiglio di Amministrazione di Novartis ha nominato <strong>Vasant (Vas) Narasimhan<\/strong>, MD, <em>Global Head of Drug Development<\/em> e <em>Chief Medical Officer<\/em>, che entrer\u00e0 in carica il 1\u00b0 febbraio 2018. Narasimhan \u00e8 membro del Comitato Esecutivo ed \u00e8 entrato in Novartis nel 2005. Jimenez, che ha svolto la funzione di CEO dal 2010, \u00e8 entrato in azienda nel 2007, dirigendo dapprima la divisione Consumer Health, per poi ricoprire la posizione di Division Head, Novartis Pharmaceuticals. Jimenez si dimetter\u00e0 ufficialmente il 31 gennaio 2018, e sar\u00e0 disponibile per consulenze e supporto su richiesta del Presidente del Consiglio di Amministrazione o dell\u2019Amministratore Delegato fino al suo definitivo ritiro da Novartis, il 31 agosto 2018.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Photo by Samuel Ferrara &nbsp; Dopo l&#8217;entrata di Pasquale Frega nel ruolo di Country President Italy e AD Novartis Farma, l&#8217;abbandono &#8211; ufficiale fra qualche giorno &#8211; di Joseph Jimenez. Gi\u00e0 Chief Executive Officer (CEO) di Novartis, Jimenez aveva informato il Consiglio di Amministrazione della sua volont\u00e0 di dimettersi dall\u2019incarico nel settembre scorso, nel dopo otto anni. Al suo posto, il Consiglio di Amministrazione di Novartis ha nominato Vasant (Vas) Narasimhan, MD, Global Head of Drug Development e Chief Medical&#8230;<\/p>\n","protected":false},"author":297440,"featured_media":9806,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[141],"tags":[],"class_list":["post-9804","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cambi ai vertici Novartis - Frezza Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/frezzapartners.com\/cambi-ai-veritici-novartis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cambi ai vertici Novartis - Frezza Partners\" \/>\n<meta property=\"og:description\" content=\"Photo by Samuel Ferrara &nbsp; Dopo l&#8217;entrata di Pasquale Frega nel ruolo di Country President Italy e AD Novartis Farma, l&#8217;abbandono &#8211; ufficiale fra qualche giorno &#8211; di Joseph Jimenez. Gi\u00e0 Chief Executive Officer (CEO) di Novartis, Jimenez aveva informato il Consiglio di Amministrazione della sua volont\u00e0 di dimettersi dall\u2019incarico nel settembre scorso, nel dopo otto anni. Al suo posto, il Consiglio di Amministrazione di Novartis ha nominato Vasant (Vas) Narasimhan, MD, Global Head of Drug Development e Chief Medical...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/frezzapartners.com\/cambi-ai-veritici-novartis\/\" \/>\n<meta property=\"og:site_name\" content=\"Frezza Partners\" \/>\n<meta property=\"article:published_time\" content=\"2018-01-25T09:58:53+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-01-26T13:39:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/frezzapartners.com\/wp-content\/uploads\/2018\/01\/samuel-ferrara-117219.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"3840\" \/>\n\t<meta property=\"og:image:height\" content=\"2560\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Frezza Partners\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Frezza Partners\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/cambi-ai-veritici-novartis\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/cambi-ai-veritici-novartis\\\/\"},\"author\":{\"name\":\"Frezza Partners\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#\\\/schema\\\/person\\\/b953d1492c9f06a9923aed3b3cbe9fc0\"},\"headline\":\"Cambi ai vertici Novartis\",\"datePublished\":\"2018-01-25T09:58:53+00:00\",\"dateModified\":\"2018-01-26T13:39:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/cambi-ai-veritici-novartis\\\/\"},\"wordCount\":167,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/cambi-ai-veritici-novartis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/samuel-ferrara-117219.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/frezzapartners.com\\\/cambi-ai-veritici-novartis\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/cambi-ai-veritici-novartis\\\/\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/cambi-ai-veritici-novartis\\\/\",\"name\":\"Cambi ai vertici Novartis - Frezza Partners\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/cambi-ai-veritici-novartis\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/cambi-ai-veritici-novartis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/samuel-ferrara-117219.jpg\",\"datePublished\":\"2018-01-25T09:58:53+00:00\",\"dateModified\":\"2018-01-26T13:39:04+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#\\\/schema\\\/person\\\/b953d1492c9f06a9923aed3b3cbe9fc0\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/cambi-ai-veritici-novartis\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/frezzapartners.com\\\/cambi-ai-veritici-novartis\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/cambi-ai-veritici-novartis\\\/#primaryimage\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/samuel-ferrara-117219.jpg\",\"contentUrl\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/samuel-ferrara-117219.jpg\",\"width\":3840,\"height\":2560},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/cambi-ai-veritici-novartis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/frezzapartners.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cambi ai vertici Novartis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#website\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/\",\"name\":\"Frezza Partners\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/frezzapartners.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#\\\/schema\\\/person\\\/b953d1492c9f06a9923aed3b3cbe9fc0\",\"name\":\"Frezza Partners\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/en\\\/author\\\/fr3zz4partn3rs\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cambi ai vertici Novartis - Frezza Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/frezzapartners.com\/cambi-ai-veritici-novartis\/","og_locale":"en_US","og_type":"article","og_title":"Cambi ai vertici Novartis - Frezza Partners","og_description":"Photo by Samuel Ferrara &nbsp; Dopo l&#8217;entrata di Pasquale Frega nel ruolo di Country President Italy e AD Novartis Farma, l&#8217;abbandono &#8211; ufficiale fra qualche giorno &#8211; di Joseph Jimenez. Gi\u00e0 Chief Executive Officer (CEO) di Novartis, Jimenez aveva informato il Consiglio di Amministrazione della sua volont\u00e0 di dimettersi dall\u2019incarico nel settembre scorso, nel dopo otto anni. Al suo posto, il Consiglio di Amministrazione di Novartis ha nominato Vasant (Vas) Narasimhan, MD, Global Head of Drug Development e Chief Medical...","og_url":"https:\/\/frezzapartners.com\/cambi-ai-veritici-novartis\/","og_site_name":"Frezza Partners","article_published_time":"2018-01-25T09:58:53+00:00","article_modified_time":"2018-01-26T13:39:04+00:00","og_image":[{"width":3840,"height":2560,"url":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2018\/01\/samuel-ferrara-117219.jpg","type":"image\/jpeg"}],"author":"Frezza Partners","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Frezza Partners","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/frezzapartners.com\/cambi-ai-veritici-novartis\/#article","isPartOf":{"@id":"https:\/\/frezzapartners.com\/cambi-ai-veritici-novartis\/"},"author":{"name":"Frezza Partners","@id":"https:\/\/frezzapartners.com\/#\/schema\/person\/b953d1492c9f06a9923aed3b3cbe9fc0"},"headline":"Cambi ai vertici Novartis","datePublished":"2018-01-25T09:58:53+00:00","dateModified":"2018-01-26T13:39:04+00:00","mainEntityOfPage":{"@id":"https:\/\/frezzapartners.com\/cambi-ai-veritici-novartis\/"},"wordCount":167,"commentCount":0,"image":{"@id":"https:\/\/frezzapartners.com\/cambi-ai-veritici-novartis\/#primaryimage"},"thumbnailUrl":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2018\/01\/samuel-ferrara-117219.jpg","articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/frezzapartners.com\/cambi-ai-veritici-novartis\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/frezzapartners.com\/cambi-ai-veritici-novartis\/","url":"https:\/\/frezzapartners.com\/cambi-ai-veritici-novartis\/","name":"Cambi ai vertici Novartis - Frezza Partners","isPartOf":{"@id":"https:\/\/frezzapartners.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/frezzapartners.com\/cambi-ai-veritici-novartis\/#primaryimage"},"image":{"@id":"https:\/\/frezzapartners.com\/cambi-ai-veritici-novartis\/#primaryimage"},"thumbnailUrl":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2018\/01\/samuel-ferrara-117219.jpg","datePublished":"2018-01-25T09:58:53+00:00","dateModified":"2018-01-26T13:39:04+00:00","author":{"@id":"https:\/\/frezzapartners.com\/#\/schema\/person\/b953d1492c9f06a9923aed3b3cbe9fc0"},"breadcrumb":{"@id":"https:\/\/frezzapartners.com\/cambi-ai-veritici-novartis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/frezzapartners.com\/cambi-ai-veritici-novartis\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/frezzapartners.com\/cambi-ai-veritici-novartis\/#primaryimage","url":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2018\/01\/samuel-ferrara-117219.jpg","contentUrl":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2018\/01\/samuel-ferrara-117219.jpg","width":3840,"height":2560},{"@type":"BreadcrumbList","@id":"https:\/\/frezzapartners.com\/cambi-ai-veritici-novartis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/frezzapartners.com\/"},{"@type":"ListItem","position":2,"name":"Cambi ai vertici Novartis"}]},{"@type":"WebSite","@id":"https:\/\/frezzapartners.com\/#website","url":"https:\/\/frezzapartners.com\/","name":"Frezza Partners","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/frezzapartners.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/frezzapartners.com\/#\/schema\/person\/b953d1492c9f06a9923aed3b3cbe9fc0","name":"Frezza Partners","url":"https:\/\/frezzapartners.com\/en\/author\/fr3zz4partn3rs\/"}]}},"_links":{"self":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/posts\/9804","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/users\/297440"}],"replies":[{"embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/comments?post=9804"}],"version-history":[{"count":0,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/posts\/9804\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/media\/9806"}],"wp:attachment":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/media?parent=9804"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/categories?post=9804"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/tags?post=9804"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}